Denali Therapeutics, Inc. (DNLI)

17.99 -0.79 (-4.21%) USD  |  NASDAQ  |  Jan 16, 16:00
17.75 -0.24 (-1.33%) After-Hours: 05:21
More

Denali Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Enovis Corp. Upgrade
Masimo Corp. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade